UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-5667 Cabot Corporation (Exact name of registrant as specified in its charter) Delaware 04-2271897 (State or other jurisdiction of incorporat ...

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|---------------------|-------|--------------------------------------|-------|-------|------------|-------------------|-------|------------------------------------------------------------| | | | Title of each class | | Section 12(b) | | | Securities | Trading symbol(s) | | Act of 1934: Name of each exchange on which registered | | | | | | Common Stock, $1 par value per share | | | CBT | | | The New York Stock Exchange | | | ...

Financial Performance - Net sales for the third quarter of fiscal 2019 were $845 million, a decrease from $854 million in the same period of fiscal 2018 [116]. - Gross profit for the third quarter of fiscal 2019 was $170 million, down from $197 million in the third quarter of fiscal 2018 [116]. - For the nine months ended June 30, 2019, net sales increased to $2,510 million compared to $2,392 million for the same period in fiscal 2018 [116]. - Gross profit for the nine months ended June 30, 2019 was $514 million, a decrease from $561 million in the same period of fiscal 2018 [116]. - Net sales decreased by $9 million in Q3 2019 compared to Q3 2018, primarily due to unfavorable foreign currency translation ($32 million) and lower volumes ($15 million) [117]. - For the first nine months of fiscal 2019, net sales increased by $118 million compared to the same period in fiscal 2018, driven by a favorable price and product mix ($146 million) [117]. - Net income attributable to Cabot Corporation was $32 million in Q3 2019, compared to $88 million in Q3 2018, and $124 million for the first nine months, compared to a net loss of $207 million in the same period of fiscal 2018 [124]. Segment Performance - Total Segment EBIT decreased by $15 million due to lower margins in Performance Chemicals, impacted by weaker pricing in China and Europe [115]. - Total segment EBIT decreased by $15 million in Q3 2019, primarily due to lower volumes and unit margins in Reinforcement Materials and Performance Chemicals [126]. - Sales in Reinforcement Materials decreased by $5 million in Q3 2019 compared to Q3 2018, primarily due to unfavorable foreign currency translation impact of $19 million and lower volumes of $8 million [131]. - EBIT in Reinforcement Materials decreased by $20 million in the first nine months of fiscal 2019 compared to the same period in fiscal 2018, driven by lower unit margins of $24 million and lower volumes of $2 million [131]. - Sales in Performance Chemicals decreased by $23 million in Q3 2019 compared to Q3 2018, primarily due to lower volumes of $13 million and unfavorable foreign currency translation of $10 million [134]. - EBIT in Performance Chemicals decreased by $49 million in the first nine months of fiscal 2019 compared to the same period in fiscal 2018, mainly due to lower volumes of $20 million and lower unit margins of $17 million [134]. - Sales in Purification Solutions increased by $3 million in Q3 2019 compared to Q3 2018, attributed to higher volumes of $3 million and a more favorable price and product mix [135]. - EBIT in Purification Solutions improved by $7 million in Q3 2019 compared to Q3 2018, driven by higher volumes of $1 million and lower fixed costs of $3 million [135]. - Specialty Fluids sales increased by $1 million to $13 million in Q3 2019 and by $32 million to $56 million in the first nine months of fiscal 2019 compared to the same periods in fiscal 2018, driven by higher project activity [138]. - EBIT for Specialty Fluids decreased by $1 million to $2 million in Q3 2019 but increased by $26 million to $24 million in the first nine months of fiscal 2019 compared to the same periods in fiscal 2018, primarily due to higher volumes [138]. Expenses and Income - Selling and administrative expenses decreased by $9 million in Q3 2019 and $15 million in the first nine months of fiscal 2019, attributed to lower incentive compensation and discretionary spending [117]. - Interest and dividend income remained consistent at $2 million in Q3 2019, while it decreased by $2 million to $6 million for the first nine months compared to the same period in fiscal 2018 [117]. - Net income attributable to noncontrolling interests decreased by $3 million in Q3 2019 and $9 million in the first nine months of fiscal 2019, mainly due to lower profitability from joint ventures in China [123]. - Income from continuing operations before income taxes increased by $172 million in the first nine months of fiscal 2019, while total segment EBIT decreased by $38 million [128]. Cash Flow and Investments - Cash and cash equivalents increased by $489 million during the first nine months of fiscal 2019, reaching $147 million, with borrowing availability under revolving credit agreements at $1,278 million [140]. - Cash provided by operating activities totaled $166 million in the first nine months of fiscal 2019, up from $143 million in the same period of fiscal 2018, driven by a net income of $146 million [143]. - Investing activities consumed $33 million of cash in the first nine months of fiscal 2019, primarily due to capital expenditures of $155 million, partially offset by $130 million from the sale of the Specialty Fluids business [144]. - Financing activities consumed $146 million of cash in the first nine months of fiscal 2019, including share repurchases of $144 million and dividend payments of $60 million [146]. - Capital expenditures for fiscal 2019 are expected to be between $230 million and $240 million, focusing on sustaining and compliance projects as well as capacity expansion [144]. Market and Operational Outlook - The company anticipates benefits in Q4 2019 from favorable pricing terms and product mix related to tire customer arrangements and higher volumes from a new plant in Wuhai, China [139]. - The company is not expecting a resolution to the U.S.-China trade dispute, which is anticipated to negatively impact the Reinforcement Materials and Performance Chemicals businesses [139]. - The unfavorable pricing environment in China significantly impacted lower unit margins in Reinforcement Materials [131]. Share Repurchase and Corporate Governance - Cabot repurchased a total of 743,300 shares of its common stock during the quarter ended June 30, 2019 [154]. - The average price paid per share for the repurchases in May 2019 was $41.93, and in June 2019 was $45.19 [154]. - As of June 30, 2019, the maximum number of shares that may yet be purchased under the repurchase plans is approximately 6,605,045 shares [154]. - The Board of Directors authorized the repurchase of up to an additional 10 million shares on July 13, 2018, increasing the total available for repurchase to approximately 11 million shares [154]. - No shares were purchased in April 2019, with a total of 7,348,345 shares remaining available for repurchase at the end of that month [154]. - The total number of shares purchased does not include 3,743 shares withheld for tax payments related to equity awards [154]. Compliance and Risk Management - The company evaluated the effectiveness of its disclosure controls and procedures as of June 30, 2019, concluding they were effective [152]. - There were no changes in internal control over financial reporting during the fiscal quarter that materially affected the company's controls [152]. - Factors that could cause actual results to differ from forward-looking statements include changes in raw material costs and demand for products [152]. - Market risks for the period ended June 30, 2019, did not differ materially from those discussed in the 2018 10-K report [152].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-5667 Cabot Corporation (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organiz ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | --- | --- | |---------------------------------------------------------------------------------------|-------------------------------------------- ...